Company
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
EyePoint Pharmaceuticals Inc is a pharmaceutical company committed to developing and commercializing innovative therapeutics to help improve the lives of patients with serious eye disorders.
3 stories
EyePoint Pharmaceuticals reports miss on results, but focus shifts to drugs poised for commercial rollout
One drug is for postoperative inflammation and the other is to prevent an eye disease
EyePoint Pharmaceuticals' stock climbs on reimbursement for Dexycu eye drops
The reimbursement code will become effective on October 1